NCT06044844View on ClinicalTrials.gov

Effectiveness of Tofacitinib in Systemic Sclerosis

PHASE2UnknownINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions

Efficacy of Tofacitinib in the Systemic Sclerosis

Interventions

DRUG

Tofacitinib

tofacitinib efficacy

Trial Locations (1)

1217

RECRUITING

Nabil Amin Khan, Dhaka

Sponsors

Collaborators (1)

Aristopharma Ltd

All Listed Sponsors

collaborator

Aristopharma Ltd

INDUSTRY

lead

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

OTHER

NCT06044844 - Effectiveness of Tofacitinib in Systemic Sclerosis | Biotech Hunter | Biotech Hunter